Valuation
- Market cap
- 3,108,000
- Revenue TTM
- $0
- Net income TTM
- $-900,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.35
Trading
- Volume
- 1,000
- Avg volume
- 4,874
- Day's range
- $0.15 – $0.17
- Shares out
- 21,141,000
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- Hold
- Price target
- —
Company profile
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, metabolic syndrome, neuropathy, and kidney functions in the United States. It develops and manufactures the eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and the eBalance Home Sy...
Show more
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, metabolic syndrome, neuropathy, and kidney functions in the United States. It develops and manufactures the eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and the eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of the shoulder, waist, back, neck, upper and lower extremities (arms and legs). The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 844 238 2692
- Website
- https://stimcell.com
- Address
- 1130 Pender Street, West, Suite 820, Vancouver, Canada
Latest news
No headlines yet.